SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-010458
Filing Date
2021-03-08
Accepted
2021-03-08 19:43:39
Documents
2
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7269
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 2327
  Complete submission text file 0000899243-21-010458.txt   11005
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REPLIGEN CORPORATION 41 SYON ST. BLDG. SUITE 100 WALTHAM MA 02453
Business Address
Bylund James (Reporting) CIK: 0001849642 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14656 | Film No.: 21723636